Quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: an insight from a phase II clinical study of zinpentraxin alfa
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2024
|
_version_ | 1824459057744838656 |
---|---|
author | Ryou, H Sirinukunwattana, K Wood, R Aberdeen, A Rittscher, J Weinberg, OK Hasserjian, R Pozdnyakova, O Peale, F Higgins, B Lundberg, P Trunzer, K Harrison, CN Royston, D |
author_facet | Ryou, H Sirinukunwattana, K Wood, R Aberdeen, A Rittscher, J Weinberg, OK Hasserjian, R Pozdnyakova, O Peale, F Higgins, B Lundberg, P Trunzer, K Harrison, CN Royston, D |
author_sort | Ryou, H |
collection | OXFORD |
description | |
first_indexed | 2025-02-19T04:35:44Z |
format | Journal article |
id | oxford-uuid:080b1a21-4f79-40f5-aca3-2b682d75d85d |
institution | University of Oxford |
language | English |
last_indexed | 2025-02-19T04:35:44Z |
publishDate | 2024 |
publisher | Wiley |
record_format | dspace |
spelling | oxford-uuid:080b1a21-4f79-40f5-aca3-2b682d75d85d2025-02-04T13:27:38ZQuantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: an insight from a phase II clinical study of zinpentraxin alfaJournal articlehttp://purl.org/coar/resource_type/c_545buuid:080b1a21-4f79-40f5-aca3-2b682d75d85dEnglishSymplectic ElementsWiley2024Ryou, HSirinukunwattana, KWood, RAberdeen, ARittscher, JWeinberg, OKHasserjian, RPozdnyakova, OPeale, FHiggins, BLundberg, PTrunzer, KHarrison, CNRoyston, D |
spellingShingle | Ryou, H Sirinukunwattana, K Wood, R Aberdeen, A Rittscher, J Weinberg, OK Hasserjian, R Pozdnyakova, O Peale, F Higgins, B Lundberg, P Trunzer, K Harrison, CN Royston, D Quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: an insight from a phase II clinical study of zinpentraxin alfa |
title | Quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: an insight from a phase II clinical study of zinpentraxin alfa |
title_full | Quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: an insight from a phase II clinical study of zinpentraxin alfa |
title_fullStr | Quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: an insight from a phase II clinical study of zinpentraxin alfa |
title_full_unstemmed | Quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: an insight from a phase II clinical study of zinpentraxin alfa |
title_short | Quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: an insight from a phase II clinical study of zinpentraxin alfa |
title_sort | quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment an insight from a phase ii clinical study of zinpentraxin alfa |
work_keys_str_mv | AT ryouh quantitativeanalysisofbonemarrowfibrosishighlightsheterogeneityinmyelofibrosisandaugmentshistologicalassessmentaninsightfromaphaseiiclinicalstudyofzinpentraxinalfa AT sirinukunwattanak quantitativeanalysisofbonemarrowfibrosishighlightsheterogeneityinmyelofibrosisandaugmentshistologicalassessmentaninsightfromaphaseiiclinicalstudyofzinpentraxinalfa AT woodr quantitativeanalysisofbonemarrowfibrosishighlightsheterogeneityinmyelofibrosisandaugmentshistologicalassessmentaninsightfromaphaseiiclinicalstudyofzinpentraxinalfa AT aberdeena quantitativeanalysisofbonemarrowfibrosishighlightsheterogeneityinmyelofibrosisandaugmentshistologicalassessmentaninsightfromaphaseiiclinicalstudyofzinpentraxinalfa AT rittscherj quantitativeanalysisofbonemarrowfibrosishighlightsheterogeneityinmyelofibrosisandaugmentshistologicalassessmentaninsightfromaphaseiiclinicalstudyofzinpentraxinalfa AT weinbergok quantitativeanalysisofbonemarrowfibrosishighlightsheterogeneityinmyelofibrosisandaugmentshistologicalassessmentaninsightfromaphaseiiclinicalstudyofzinpentraxinalfa AT hasserjianr quantitativeanalysisofbonemarrowfibrosishighlightsheterogeneityinmyelofibrosisandaugmentshistologicalassessmentaninsightfromaphaseiiclinicalstudyofzinpentraxinalfa AT pozdnyakovao quantitativeanalysisofbonemarrowfibrosishighlightsheterogeneityinmyelofibrosisandaugmentshistologicalassessmentaninsightfromaphaseiiclinicalstudyofzinpentraxinalfa AT pealef quantitativeanalysisofbonemarrowfibrosishighlightsheterogeneityinmyelofibrosisandaugmentshistologicalassessmentaninsightfromaphaseiiclinicalstudyofzinpentraxinalfa AT higginsb quantitativeanalysisofbonemarrowfibrosishighlightsheterogeneityinmyelofibrosisandaugmentshistologicalassessmentaninsightfromaphaseiiclinicalstudyofzinpentraxinalfa AT lundbergp quantitativeanalysisofbonemarrowfibrosishighlightsheterogeneityinmyelofibrosisandaugmentshistologicalassessmentaninsightfromaphaseiiclinicalstudyofzinpentraxinalfa AT trunzerk quantitativeanalysisofbonemarrowfibrosishighlightsheterogeneityinmyelofibrosisandaugmentshistologicalassessmentaninsightfromaphaseiiclinicalstudyofzinpentraxinalfa AT harrisoncn quantitativeanalysisofbonemarrowfibrosishighlightsheterogeneityinmyelofibrosisandaugmentshistologicalassessmentaninsightfromaphaseiiclinicalstudyofzinpentraxinalfa AT roystond quantitativeanalysisofbonemarrowfibrosishighlightsheterogeneityinmyelofibrosisandaugmentshistologicalassessmentaninsightfromaphaseiiclinicalstudyofzinpentraxinalfa |